The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

THE PROPHYLAXIS OF CARDIAC COMPLICATIONS IN ELECTROSHOCK THERAPY

Published Online:https://doi.org/10.1176/ajp.102.3.316

The cases cited suggest that premedication in patients with cardiac disease is an effective prophylaxis for the development of cardiac complications. Often where cardiac complications occur they are preceded by various arrhythmias and these may be controlled with quinidine sulfate. Vasodilator drugs may be useful in preventing cardiac complications of vascular origin but there was no opportunity to test this. No mention in the literature of such premedication has come to attention and the writer has had no opportunity in recent years of developing this work. A wider trial and close observation of such premedication by workers now engaged in this field may enable more patients in the older age group with psychiatric conditions to obtain the benefit of electroshock treatment.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.